CS MEDICA Offers Shareholders the Opportunity to Transfer Delisted Shares Before 31 December 2025
Administrative service to help shareholders avoid unnecessary custody fees; no payment involved.
CS MEDICA A/S (“CS MEDICA” or the “Company”) introduces an administrative initiative to support shareholders holding CS MEDICA shares following the Company’s delisting.
A number of shareholders have recently experienced additional custody fees charged by banks for holding delisted securities. To assist these shareholders, CS MEDICA now offers a voluntary and cost-free option to transfer their CS MEDICA shares to the Company before 31 December 2025.
This initiative is purely administrative and intended for shareholders who no longer wish to hold delisted shares and who—depending on individual circumstances and tax regulations—may be able to document a tax-deductible loss once the shares are removed from their custody account.
CS MEDICA does not provide tax advice, and shareholders are encouraged to consult their own advisor regarding potential tax effects.
Important Clarifications
- The transfer is fully voluntary.
- The Company is not permitted to provide any form of payment, compensation, or consideration.
- Transferred shares will therefore be received at a value of 0 DKK per share, in accordance with applicable regulations.
- The initiative does not constitute a buyback, tender offer, or incentive of any kind.
Shareholders wishing to proceed are welcome to contact CS MEDICA directly for guidance and the required transfer details:
Focus on Stability and Future Readiness
CS MEDICA continues to work systematically on strengthening its operational and financial foundation with the long-term aim of enabling a future relisting. While no specific timeline can currently be provided, the Company remains fully committed to maintaining transparent communication and supporting shareholders throughout this process.
Legal Disclaimer
This initiative is an optional administrative service made available to shareholders. It does not constitute a share buyback, tender offer, invitation to sell, or any form of financial incentive. No payment or consideration will be provided for transferred shares. CS MEDICA does not provide financial, legal, or tax advice. Shareholders are responsible for seeking independent professional advice regarding any potential tax implications.